Optimal Care With Guselkumab in Crohn's Disease / OPTIM Study A Prospective Open Label Interventional, Multicenter Study

Clinical trial NCT07616687 · RECRUITING

Trial details

NCT number: NCT07616687
Sponsor: Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Crohn Disease (CD)Intensification

Start date: 2026-06-18
Primary completion: 2029-03-15
Enrollment: 210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.